We characterized two proglucagon cDNAs from the intestine of the sea lamprey Petromyzon marinus. As in other vertebrates, sea lamprey proglucagon genes encode three glucagon-like sequences, glucagon, and glucagon-like peptides 1 and 2 (GLP-1 and GLP-2). This observation indicates that all three glucagon-like sequences encoded by the proglucagon gene originated prior to the divergence of jawed and jawless vertebrates. Estimates of the rates of evolution for the glucagon-like sequences suggest that glucagon originated first, about 1 billion years ago, while GLP-1 and GLP-2 diverged from each other about 700 MYA. The two sea lamprey intestinal proglucagon cDNAs have differing coding potential. Proglucagon I cDNA encodes the previously characterized glucagon and the glucagon-like peptide GLP-1, while proglucagon II cDNA encodes a predicted GLP-2 and, possibly, a glucagon. The existence of two proglucagon cDNAs which differ with regard to their potential to encode glucagon-like peptides suggests that the lamprey may use differential gene expression as a third mechanism, in addition to alternative proteolytic processing and mRNA splicing, to regulate the production of proglucagon-derived peptides.
Introduction
Glucagon is a 29-amino-acid peptide hormone involved in the regulation of carbohydrate, amino acid, and lipid metabolism (Lefèbvre 1995) . Glucagon is secreted by the A cells of the mammalian pancreatic islets in response to low glucose levels and acts as the counterregulatory hormone to insulin (Lefèbvre 1995) . In mammals, glucagon is processed from a larger precursor. Alternative proteolytic processing results in the production of glucagon-like peptides 1 and 2 (GLP-1 and GLP-2) in intestinal L cells and some neurons of the brain stem and hypothalamus (Mojsov et al. 1986; Ørskov et al. 1986 ). While the function of glucagon appears to be conserved among vertebrates, the function of GLP-1 varies. In tetrapods (e.g., mammals and amphibians), GLP-1 is an incretin hormone that is produced by intestinal L cells which potentiates the release of insulin by pancreatic islet B cells and thus executes insulin-like physiological actions (Mojsov, Weir, and Habener 1987; Drucker 1998) . In contrast, GLP-1 in bony fish performs glucagon-like activity and is produced by both the pancreas and the intestine (Dugay and Mommsen 1994; Plisetskaya and Mommsen 1996) . The function of GLP-2 has so far been described only for mammals, for which it was identified to be an intestinal growth factor (Drucker et al. 1996) .
The three glucagon-like sequences found in mammalian proglucagon genes are encoded by separate exons (Heinrich, Gros, and Habener 1984; White and Saunders 1986; Philippe 1991) . It has been suggested that the three peptides originated via triplication of an ancestral exon that encoded a glucagon-like peptide (Philippe 1991; Holst and Ørskov 1994; Laser and Philippe 1997; Hoyle 1998) . The first proglucagon cDNAs were isolated from the pancreas of bony fish (anglerfish) and birds (chicken), and the predicted proglucagon contained only two glucagon-like sequences, glucagon and a glucagon-like peptide (Lund et al. 1982 (Lund et al. , 1983 Hasegawa et al. 1989) . Recently, additional proglucagon cDNAs from nonmammalian vertebrates have been characterized, and they were found to encode GLP-2-like molecules (Irwin and Wong 1995; Chen and Drucker 1997; Irwin et al. 1997 ). These results indicate that the triplication of a glucagon-like exon preceded the divergence of bony fish and mammals, and that this structure has been maintained since then. The absence of GLP-2 from the cDNA initially isolated from the pancreas of anglerfish and chickens (Lund et al. 1982 (Lund et al. , 1983 Hasegawa et al. 1989 ) was due to alternative splicing. GLP-2-encoding cDNAs from the trout and chicken were isolated from the intestine (Irwin and Wong 1995) .
The discovery that proglucagon mRNAs are alternatively spliced in some species (fish, frogs, birds, and lizards) has led to the identification of GLP-2 sequences in species in which they were previously believed not to exist (Irwin and Wong 1995; Chen and Drucker 1997) . A previous phylogenetic analysis of proglucagon gene sequences by Lopez et al. (1984) concluded that GLP-2 was of ancient origin and that glucagon and GLP-1 were more closely related to each other. The early origin of GLP-2 was inferred using the rate of evolution of GLP-2 within mammals, while the rates of evolution of glucagon and GLP-1 were inferred from anglerfish-to-mammal comparisons (Lopez et al. 1984) . In our characterization of GLP-2-encoding proglucagon cDNAs from nonmammalian vertebrates (Irwin and Wong 1995; Irwin et al. 1997) , we recognized that the GLP-2 sequence was evolving more rapidly in nonmammalian vertebrates than within mammals. This observation led us to hypothesize that GLP-2 may have a more recent origin.
To test our hypothesis of a recent origin for GLP-2, we isolated and characterized proglucagon cDNAs from the sea lamprey Petromyzon marinus, whose lineage can be traced to the earliest vertebrates, the Ag- natha. It has been hypothesized that pancreatic endocrine cells evolved from gut endocrine cells and that the lampreys may represent an intermediate in which some but not all endocrine cell types have migrated to the pancreas (Falkmer and Van Noorden 1983) . Insulin-and somatostatin-producing endocrine cells have been identified in the pancreas, but glucagon-producing cells are found only in the intestine (Cheung et al. 1991; Youson and Elliott 1993) . We isolated and characterized two different sea lamprey intestinal proglucagon cDNAs and show that sea lamprey proglucagon does encode GLP-2. Comparison of lamprey and mammalian sequences of proglucagon-derived peptides suggests that GLP-1 and GLP-2 have had a more recent common ancestor than either has with glucagon, and that they diverged from each other just prior to the origin of vertebrates. The existence of two intestinal proglucagon cDNAs with differing coding potentials suggests that the regulation of the production of proglucagon-derived peptides in the lamprey differs from that described for other vertebrates.
Materials and Methods Materials
Oligonucleotides for PCR were obtained from ACGT (Toronto, Ontario, Canada) and are listed in table 1. Radioisotopes were purchased from Amersham (Oakville, Ontario, Canada). pCRII and pCR2.1 cloning vectors were purchased from Invitrogen (San Diego, Calif.), and the ZAPII cDNA synthesis kit was from Stratagene (San Diego, Calif.). Tissues were obtained from sea lampreys captured during their upstream spawning migration in the Humber River and Duffins Creek near Toronto, Ontario, Canada. Following anesthetization with MS-222, the animals were killed by decapitation. The caudal islet organ, the intestine, and the liver were extirpated, immediately frozen in liquid nitrogen and ultimately stored at Ϫ80ЊC until use.
Isolation of Proglucagon cDNA Clones
Degenerate primers were synthesized based on the known N-terminal amino acid sequence of glucagon (HSEGTF) and the midportion of the glucagon-like peptide sequence (FTNDMT) (Conlon, Nielson, and Youson 1993 ; see table 1). The glucagon primer was the sense primer, whereas the GLP-1 primer was the antisense primer. Reverse transcription-polymerase chain reaction (RT-PCR) was as previously described (Irwin and Wong 1995) , using mRNA isolated from the intestine of a sea lamprey in the spawning (nonfeeding) phase of its life cycle. Products of RT-PCR were cloned into pCRII. A lambda ZAP II cDNA library was constructed (composed of approximately 2,000,000 independent clones) from mRNA purified from the intestine of a single sea lamprey that was in the spawning phase of its life cycle. The 5Ј and 3Ј ends of proglucagon cDNAs were amplified from subsets of the library using a nested PCR approach. Each end was amplified using two nested gene-specific primers (see table 1) and nested pairs of lambda ZAP vector primers (for the 5Ј-end primers, M13 reverse and then T7; for the 3Ј-end primers, M13 forward and then T3). PCR products were cloned into pCRII or pCR2.1. At least three clones were sequenced for each end of both proglucagon cDNAs.
Northern Blot and RT-PCR Analysis
RNA was isolated from sea lamprey tissues (intestine, pancreas, and liver) with RNAsol (Canadian Life Technologies, Burlington, Ontario, Canada). To identify the length of the proglucagon I transcript, RNA was separated in a formaldehyde agarose gel (Sambrook, Fritsch, and Maniatis 1983) . Proglucagon I mRNA was detected by hybridization of the RNA at high stringency with a portion of the pancreatic cDNA that encodes glucagon, GLP-1, and GLP-2, as well as 3Ј untranslated sequences (bases 202-796, fig. 2 ). Hybridization and washing conditions were as previously described (Irwin and Wong 1995) . RT-PCR using pairs of gene-specific primers (table 1) assayed tissue-specific expression of each of the two proglucagon genes. The structures of two mRNAs were determined by RT-PCR, and 3Ј rapid amplification of cDNA ends (RACE) was used to test for alternative splicing. RACE was as previously de- scribed (Irwin and Wong 1995) . First-strand cDNA for RT-PCR and 3Ј RACE was synthesized with a kit from Canadian Life Technologies (Burlington, Ontario, Canada); random primers were used to prime cDNA for RT-PCR, and a modified oligo dT primer (see table 1) was used for 3Ј RACE.
Sequence Analysis DNA sequence data were assembled and analyzed with the MacDNAsis 3.2 computer package (Hitachi, Sun Bruno, Calif.). Differences and divergences (and standard errors) between DNA and amino acid sequences were calculated with MEGA 1.01 (Kumar, Tamura, and Nei 1993) . Rates of evolution for glucagon-like sequences and dates of divergence of these sequences were essentially as described by Lopez et al. (1984) . Briefly, we aligned the DNA sequences from the glucagon and glucagon-like peptides (GLP-1 and GLP-2) from lampreys and humans. Only the 29 codons that are shared by all three peptides were used in the analysis. Nonsynonymous divergences (K a ) were estimated with Jukes-Cantor correction for multiple hits. Rates for each of the three peptides were calculated assuming a divergence date of 564 Myr between lampreys and humans (see Kumar and Hedges 1998) .
Results

Isolation of Sea Lamprey Proglucagon cDNAs
Initial cDNA clones for sea lamprey proglucagon were isolated by RT-PCR using degenerate primers specific for the known sequences of sea lamprey glucagon and a glucagon-like peptide (Glu5Ј and Glp; see table 1 and fig. 1 ; Conlon, Nielson, and Youson 1993) . With our degenerate primer pair, we obtained a single DNA fragment that was cloned. The DNA sequences of five clones yielded a single cDNA sequence that predicted a glucagon and partial N-terminal GLP-1 amino acid sequences that were identical to that deduced by peptide sequencing (Conlon, Nielson, and Youson 1993) . The complete cDNA sequence of sea lamprey proglucagon I was extended in the 3Ј and 5Ј directions by PCR amplification of a cDNA library with gene-specific and vector-specific primers (see fig. 1 and table 1). The longest cDNA clone obtained predicted a mRNA sequence of 796 bases for sea lamprey proglucagon I ( fig. 2) . In addition to our proglucagon I cDNA clones, we obtained additional clones that differed from the proglucagon I sequence. The proglucagon II sequence was also extended by PCR amplifications of the cDNA library (see fig. 1 and table 1). Our longest cDNA clones for proglucagon II predict an mRNA sequence of 738 bases ( fig. 3 ).
Structure of Sea Lamprey Proglucagon mRNAs
Northern blot analysis identified a single proglucagon I mRNA transcript of approximately 1,000 bases in the intestine and the pancreas (fig. 4) . The size of the mRNA suggests that we have a nearly full length cDNA sequence (796 bases plus polyA tail). Expression of proglucagon I was detected in intestinal mRNA isolated from sea lampreys in both the parasitic and the spawner phases of their life cycle ( fig. 4) . Levels of expression of proglucagon I mRNA are similar in both the pancreas and the intestine. RT-PCR analysis indicated that proglucagon II mRNAs were present in the intestine (both parasitic and spawner) and the pancreas (data not shown).
Proglucagon mRNAs are alternatively spliced in many vertebrate species (Irwin and Wong 1995; Chen and Drucker 1997; Irwin et al. 1997) ; thus, we attempted to identify alternatively spliced forms of the sea lamprey proglucagon I mRNA. Previously described patterns of alternative splicing of proglucagon alter the coding potential of the 3Ј end of the mRNA (Irwin and Wong 1995; Chen and Drucker 1997; Irwin et al. 1997 ) and result in mRNAs that do or do not encode GLP-2. We used 3Ј RACE to amplify the 3Ј end of the proglucagon I mRNA in both the intestine and the pancreas using two nested primers that are upstream of the GLP-2 sequence (I-5.1 and I-5.2; see fig. 1 ). All of the 3Ј RACE products from both tissues were identical in size and sequence, suggesting that all the proglucagon I mRNAs were of the same structure.
The characterization of the sea lamprey proglucagon II cDNAs implied a novel potential alternative splicing pattern. The observation that the proglucagon II mRNA was missing a GLP-1 sequence (see below) suggested that a GLP-1-encoding exon might be alternatively spliced. This pattern of alternative splicing would be similar to the alternative splicing of the GLP-2-encoding exon found in the Xenopus laevis proglucagon gene (Irwin et al. 1997) .
To determine if an exon encoding GLP-1 was alternatively spliced in the sea lamprey proglucagon II transcript, we used primers near the 5Ј end of the coding region (II-5.1, within the signal peptide) and downstream of GLP-2 (II-3.1) to amplify most of the coding region (see fig. 1 ). Again, only a single amplified DNA fragment was detected by RT-PCR amplification in the pancreas and the intestine, and all clones generated from these fragments had identical DNA sequences.
Structure of the Sea Lamprey Proglucagon cDNAs and Predicted Protein Products
Our proglucagon I cDNA predicts an amino acid sequence that encodes peptide sequences identical to glucagon and glucagon-like peptide sequences ( fig. 5) deduced by peptide sequencing from intestinal extracts of the same species of lamprey (Conlon, Nielson, and Youson 1993) . Carboxy-terminal to the GLP-1 sequence of sea lamprey proglucagon I, the open reading frame predicts an additional 47 amino acid residues ( fig. 2 ). Within this sequence, an additional glucagon-like peptide sequence was observed, although a gap of five amino acid residues had to be inserted into the highly conserved N-terminal region of this sequence for maximal alignment ( fig. 5 ). The C-terminal location of this glucagon-like sequence suggests that it corresponds to the GLP-2 sequences of other vertebrate proglucagons.
The proglucagon II cDNA sequence predicted a glucagon sequence that differed from the proglucagon I glucagon sequence at eight residues ( fig. 5) . The glucagon sequence encoded by proglucagon II was found to be equally similar to the glucagon sequences from Lampetra fluviatilis (river lamprey) (Conlon et al. 1995) and Geotria australis (Wang et al. 1999a) . A unique feature of our proglucagon II cDNA was that it appeared to contain only two glucagon-like sequences, a glucagon (glucagon II) and a GLP-2 (GLP-2 II), but not a GLP-1 sequence (figs. 4 and 6). Predicted sea lamprey proglucagon I and II both have potential signal peptides to allow secretion of processed products (i.e., glucagon, GLP-1, and GLP-2). Potential signal peptidase cleavage sites predict a 21-amino-acid residue signal peptide for both proglucagons (figs. 2, 4, and 6). Mature proglucagon would thus possess a 21-(proglucagon I) or 20-amino-acid-long (proglucagon II) N-terminal region that corresponds to the glicentin-related pancreatic peptide (GRPP) of mammalian proglucagons.
Discussion
Predicted Sea Lamprey Proglucagon-Derived Peptides
Our proglucagon cDNAs predict glucagon-like sequences similar to glucagon, GLP-1, and GLP-2. The proglucagon I cDNA ( fig. 2 ) encodes sequences that are identical to purified glucagon and glucagon-like peptide from the sea lamprey (Conlon, Nielson, and Youson 1993) . The glucagon-like peptide sequence is homologous to GLP-1 sequences of other vertebrates ( fig. 5 ). Carboxy-terminal to the GLP-1 sequence, there is a sec- ond glucagon-like sequence that appears to correspond to GLP-2 ( fig. 2) . A pair of basic amino acid residues precedes the GLP-2 sequence that should allow processing of this peptide from proglucagon I (see fig. 2 ). Maximal alignment of this GLP-2 sequence to other GLP-2 sequences requires the placement of a gap of five amino acids between residues 3 and 4 (figs. 5 and 6). These missing residues in GLP-2 of proglucagon I correspond to well-conserved residues in all glucagon-like sequences; e.g., glycine at position 4 is otherwise perfectly conserved (see fig. 5 ). Since the conserved Nterminal sequences have been shown to be important for receptor recognition for glucagon and GLP-1 (Adelhorst et al. 1994; Gallwitz et al. 1994; Unson and Merrifield 1994) , it is likely that they are also important for recognition of the GLP-2 receptor. Therefore, we conclude that the GLP-2-like sequence encoded by proglucagon I probably does not function in the same manner as other vertebrate GLP-2 sequences. This GLP-2-like peptide either is nonfunctional or has acquired a new function.
In contrast to the sea lamprey proglucagon I sequence, a single basic residue (figs. 4 and 6) precedes the glucagon peptide encoded by the sea lamprey proglucagon II cDNA. The presence of a single residue, rather than paired basic residues, raises the possibility that this glucagon peptide is not processed from the proglucagon II precursor. Prohormone convertases typically cleave precursor molecules at paired basic amino acid sites, but in some cases, certain convertases cleave at single basic amino acid sites (Steiner et al. 1992; Dhanvantari, Seidah, and Brubaker 1996) . The failure of a convertase to cleave, or to cleave at low efficiency, at the single basic residue N-terminal to glucagon in proglucagon II may explain the observation that only a sin- gle glucagon was isolated from intestinal tissue (Conlon, Nielson, and Youson 1993) . The GLP-2 sequence encoded by proglucagon II, unlike the GLP-2 sequence encoded by proglucagon I, does not require any insertions or deletions for maximal alignment to other vertebrate GLP-2 sequences (see fig. 4 ). The GLP-2 II sequence is preceded by paired basic residues and therefore may by processed to yield a 32-amino-acid-long peptide. We hypothesize that the GLP-2 encoded by proglucagon II is the functional GLP-2 in the sea lamprey.
Sea Lamprey Proglucagon cDNAs Differ in Coding Potential for Intestinal Proglucagon-Derived Peptides
The two sea lamprey intestinal proglucagon cDNAs that we characterized differ in coding potential (figs. 2, 4, and 6). The proglucagon I cDNA encodes glucagon and GLP-1, while the proglucagon II cDNA encodes GLP-2 and possibly glucagon. Proglucagon-derived peptides GLP-1 and GLP-2 are secreted in parallel in equimolar amounts by mammalian intestinal L cells (Drucker 1998) . Differing amounts of GLP-1 and GLP-2 can be produced in some vertebrate species due to alternative splicing. In fish, GLP-1, but not GLP-2, can be produced in the pancreas (Irwin and Wong 1995) . All intestinal transcripts in trout and other vertebrate species should allow equimolar production of GLP-1 and GLP-2 (Irwin and Wong 1995; Chen and Drucker 1997; Irwin et al. 1997) . As a consequence of having two proglucagon cDNAs (produced by different genes) that encode different sets of hormones, the level of production of each hormone can potentially be regulated at the level of transcription in the sea lamprey.
Origin of Glucagon-like Sequences
Our characterization of sea lamprey proglucagon cDNAs demonstrates that there are at least three glucagon-like sequences encoded in the lamprey genome (figs. 2, 4, and 5). This observation indicates that the origin of these three peptides (glucagon, GLP-1, and GLP-2) occurred prior to the divergence of lampreys and perhaps the original vertebrates. However, sequences clearly homologous to glucagon or glucagon-like peptides have not yet been identified in any invertebrate species (Hoyle 1998) . To estimate the date of origin of the three glucagon-like hormones, we used the same approach as Lopez et al. (1984) , except that we used our new sea lamprey cDNA sequences. Shown in table 2 are the divergence rates for each of the three glucagon-like hormones that were calculated assuming a divergence time of 564 Myr between lampreys and other vertebrates (see Kumar and Hedges 1998) . For divergence calculations, we used portions of the cDNAs that encoded both sea lamprey glucagons, GLP-1 from proglucagon I, and GLP-2 from proglucagon II. We did not use the portion of proglucagon I cDNA that encoded GLP-2, since this predicted peptide sequence requires an insertion of a five-amino-acid gap for maximum identity (see figs. 5 and 6). We also hypothesized that GLP-2 encoded by proglucagon I may not be functional (see above). Our estimated divergence rates for each of the glucagon-like hormone sequences are similar to those estimated by Lopez et al. (1984) , except for the rate estimated for GLP-2. We estimated a rate of 0.44 ϫ 10 Ϫ9 nonsynonymous substitutions per year for GLP-2, which is higher than the rate of 0.25 ϫ 10 Ϫ9 substitutions per year estimated by Lopez et al. (1984) . GLP-2 is evolving at a slower rate within mammals than it is in the remaining vertebrates. We used our estimated divergence rates to calculate the divergences of the sequences encoding glucagon, GLP-1, and GLP-2 from each other for both the sea lamprey and the human cDNA sequences (table 3) . Similar divergence dates were estimated from both the lamprey and the human proglucagon cDNA sequences. The sequence encoding glucagon diverged from sequences encoding both GLP-1 and GLP-2 approximately 900-1000 MYA, while the sequences encoding GLP-1 and GLP-2 have a more recent divergence of about 677-688 MYA (see fig. 7 ). Similar divergence dates were estimated if we calculated gamma distances between the peptide sequences (data not shown). These estimates of dates indicate that all three glucagon-like hormone sequences encoded by the proglucagon gene must have origins early in chordate or metazoan evolution.
Duplication of Proglucagon Genes Within the Lamprey Lineage
A single glucagon peptide was isolated from intestinal extracts from sea lamprey and river lamprey, while two glucagons were isolated from the Southern Hemisphere lamprey G. australis (Conlon, Nielson, and Youson 1993; Conlon et al. 1995; Wang et al. 1999a ). These observations suggested that there were two proglucagon genes in lampreys, with both genes expressed in the intestine of Geotria, while one was predominantly expressed in the intestines of the two Northern Hemisphere (sea and river) lamprey species (Wang et al. 1999a ). Alternatively, a single proglucagon gene could encode the two glucagons, a situation analogous to that of the multiple GLP-1 sequences encoded by the X. laevis proglucagon gene (Irwin et al. 1997) . Our characterization of two proglucagon cDNAs from the intestine of the sea lamprey supports the conclusion that there are two different proglucagon genes in lampreys. The glucagon peptide encoded by the proglucagon I cDNA is most similar to the Geotria II glucagon, while the potential glucagon encoded by proglucagon II is most similar to Geotria I and the glucagon isolated from the river lamprey ( fig. 5) . Thus, the duplication of the proglucagon gene occurred prior to the earliest divergence of modern lampreys, that between the Northern (sea and river) and Southern (Geotria) Hemisphere species (Potter and Hilliard 1987) . Wang et al. (1999a) suggested that the isolation of a single glucagon peptide from sea and river lampreys may be explained by species-specific expression of the two proglucagon genes. Our isolation of cDNAs from two sea lamprey proglucagon genes shows that both can be expressed, although reduced production of the hormone glucagon from the proglucagon II gene may be due to the absence or reduced proteolytic processing of the precursor polypeptide (see above). Species-specific proteolytic processing of the two proglucagons, rather than species-specific gene expression, may regulate the production of glucagon.
The isolation of two distinct proglucagon cDNAs from sea lampreys allows us to use the same approach described above for glucagon-like sequences to estimate the date of divergence of these two proglucagon cDNAs. For the sequences that encode glucagon, a divergence date of 478 MYA is estimated from nonsynonymous divergences (table 3) . A similar value was again obtained with gamma distances from the predicted peptide sequences (data not shown). The only other parts of the predicted proglucagon sequences that appear to be homologous and alignable are the GLP-2-like peptides. Using the sequences that encode the GLP-2-like sequences, we estimated a divergence date of nearly 300 MYA (see fig. 7 ). These divergence dates, together with the observation that the predicted N-terminal region (including the signal peptide) and intervening peptide sequences share little similarity ( fig. 6 ), support the suggestion that the duplication of the proglucagon gene occurred hundreds of millions of years ago in the lamprey lineage, possibly early in lamprey evolution. To date, the lamprey lineage is traced back to approximately 250 MYA, when lampreys likely evolved from a naked anaspid derivative of the ostracoderms (Forey and Janvier 1994) .
Duplication of Lamprey Hormone Genes
We have shown that the proglucagon gene has been duplicated in the lamprey lineage. At least two other hormone genes are also known to have been duplicated in lampreys, the proopiomelanocortin (POMC) and peptide tyrosine-tyrosine (PYY) genes (Heinig et al. 1995; Takahashi et al. 1995; Wang et al. 1999b ). For both of these genes the gene duplication events must have also been early, rather than recent, in lamprey evolution as the peptides encoded by these differ greatly (Heinig et al. 1995; Takahashi et al. 1995; Wang et al. 1999b) . A possible explanation for the origin of these duplicated genes is a genome duplication event, an event that may also explain the large number of chromosomes found in lampreys (Potter and Rothwell 1970; Robinson and Potter 1981) .
The specialization of duplicate proglucagon genes in the sea lamprey to encode different peptides is not unique to the proglucagon gene. The two POMC-like genes of lamprey (POM and POC) appear to have differing coding potentials (Heinig et al. 1995; Takahashi et al. 1995) . The POM gene encodes melanotropin A and B and a beta-endorphin, while the POC paralog encodes nasohypophysial factor, corticotropin, and a different beta-endorphin (Takahashi et al. 1995) . Like proglucagon, a single gene in most vertebrate species typically encodes POMC. Genome duplication may have allowed lampreys to use a novel transcriptional mechanism, in addition to posttranslational control, to regulate the production of hormones encoded by the POMC-like and proglucagon genes.
